NRX Pharmaceuticals (NRXP) Enterprise Value Growth (1y) (2018 - 2026)
NRX Pharmaceuticals (NRXP) Enterprise Value Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | NRX Pharmaceuticals | 137.57 Mn | 130.87 Mn | 437,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -21.82% |
| Dec 31, 2025 | -440.33% |
| Sep 30, 2025 | -349.00% |
| Jun 30, 2025 | -52.63% |
| Mar 31, 2025 | -316.98% |
| Dec 31, 2024 | 68.60% |
| Sep 30, 2024 | 82.03% |
| Jun 30, 2024 | 87.31% |
| Mar 31, 2024 | 92.01% |
| Dec 31, 2023 | 77.09% |
| Sep 30, 2023 | 51.22% |
| Jun 30, 2023 | 39.02% |
| Mar 31, 2023 | 58.94% |
| Dec 31, 2022 | 27.35% |
| Sep 30, 2022 | 53.07% |
| Jun 30, 2022 | -83.38% |
| Mar 31, 2022 | -202.92% |
| Dec 31, 2021 | -1,385.33% |
| Sep 30, 2021 | -2,919.48% |
| Jun 30, 2021 | -1,244.03% |